| Serial Number | 79288175 |
| Word Mark | SOSEI HEPTARES |
| Filing Date | Thursday, April 9, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 30, 2022 |
| Registration Number | 6829584 |
| Registration Date | Tuesday, August 30, 2022 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 14, 2022 |
| Goods and Services | Biological products for medical use in chemical and biological drug discovery, lead identification and diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological products for therapeutic purposes, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; proteins for medical use in chemical and biological drug discovery, lead identification and diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; medicines, namely, diagnostic preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; cleaning agent for medical use, namely, medical cleansers for skin wounds; biological formulation for medical use in developing chemical and biological pharmaceutical products, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological formulation for medical use in identifying lead chemical and biological products, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological formulation for medical diagnostic use, namely, diagnostic preparations for medical use; biological formulation for therapeutic use, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; proteins and G-protein-coupled receptors for medical use in drug discovery; biologicals and small chemical entities, including proteins, G-protein-coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for therapeutic purposes, namely, diagnostic preparations for medical use; proteins, G-protein-coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for use in medical diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; medical oiled paper; drug delivery agents in the form of edible pharmaceutical wafers for wrapping powdered pharmaceuticals; gauze for dressings; specialized capsules for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; eye patches for medical purposes, ear bandages; menstrual bands being sanitary pads; menstrual tampons; menstrual napkins, namely, menstrual symptom treatment preparations; menstrual underwear, namely, panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; collodion for pharmaceutical purposes; cotton swabs for medical purposes; breast-nursing pads |
| Translation of Words in Mark | The English translation of "SOSEI" in the mark is "DO AS YOU WISH". |
| Goods and Services | chemical products and proteins for manufacturing chemical and biological pharmaceutical products; chemical products and proteins for the scientific research of chemical and biological pharmaceutical products; chemical products and proteins for diagnostic use, except medical or veterinary uses, namely, diagnostic preparations for scientific use; proteins and specifically proteins in the nature of G-protein-coupled receptors for manufacturing pharmaceutical products; proteins and specifically proteins in the nature of G-protein-coupled receptors, for the scientific research of pharmaceutical products; chemicals and proteins for chemical and biological drug discovery, lead identification and diagnostics, namely, chemical and biological preparations for use in scientific purposes; proteins and G-protein-coupled receptors for drug discovery purpose, namely, proteins and biological preparations for use in scientific research; chemicals preparations and biologicals preparations for scientific research purposes, being proteins, transmembrane proteins and G proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for chemical and biological drug discovery, lead identification and diagnostics; proteins, including transmembrane proteins and G-proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, all for use in scientific pharmaceutical research and scientific pharmaceutical research in the nature of drug discovery purposes |
| Goods and Services | Bio-technology, pharmaceutical and scientific testing, research and development; biological research services; research and development services in the pharmaceutical and biopharmaceutical fields;, research and development services in the pharmaceutical and biopharmaceutical fields, namely, in the field of technologies related to proteins and G-protein-coupled receptors; research services in biology and chemistry fields; pharmaceutical research services in chemical and biological drug discovery and development; scientific and pharmaceutical research and development services for identifying lead chemical compounds; scientific analysis and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; pharmaceutical research and development in the nature of research, creation, development and provision of chemical and biological drug targets for non-medical scientific screening purposes; technical diagnostic testing services, namely, scientific and pharmaceutical research and development; scientific research, analysis and examination for identification of compounds through automated screening processes, being scientific and pharmaceutical research and development; research and development services in chemical and biological pharmaceutical development; provision of information, advisory services and consultancy relating to the aforesaid services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 26, 2020 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 26, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 26, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Nxera Pharma Co., Ltd |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 98 - Unknown |
| Address | JP |
| Party Name | Sosei Group Corporation |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | Sosei Group Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | Sosei Group Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Friday, June 26, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 25, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, June 26, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, June 30, 2020 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Tuesday, August 11, 2020 | REFUSAL PROCESSED BY MPU |
| Tuesday, August 11, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, June 29, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 30, 2020 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, June 30, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, July 2, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, July 3, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, February 4, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 4, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, August 30, 2020 | REFUSAL PROCESSED BY IB |
| Thursday, February 4, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 9, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, March 5, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, March 5, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Friday, March 5, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, March 5, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, March 9, 2021 | FINAL REFUSAL WRITTEN |
| Tuesday, March 9, 2021 | FINAL REFUSAL E-MAILED |
| Thursday, September 9, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, December 1, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Thursday, September 9, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 9, 2021 | CORRESPONDENCE E-MAILED |
| Thursday, September 9, 2021 | SUSPENSION LETTER WRITTEN |
| Wednesday, December 1, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Sunday, December 19, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Monday, March 14, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Saturday, April 30, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, May 5, 2022 | ASSIGNED TO LIE |
| Thursday, May 5, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 5, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 6, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 25, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 8, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 8, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, June 14, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 14, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 5, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 30, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, December 7, 2022 | FINAL DISPOSITION PROCESSED |
| Tuesday, August 30, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Friday, November 4, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, November 30, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, December 7, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, December 27, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, June 14, 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |